CH534675A - Verfahren zur Herstellung von 9a-Fluor-16-fluor-methylenprednisolon-21-önanthat - Google Patents
Verfahren zur Herstellung von 9a-Fluor-16-fluor-methylenprednisolon-21-önanthatInfo
- Publication number
- CH534675A CH534675A CH1648272A CH1648272A CH534675A CH 534675 A CH534675 A CH 534675A CH 1648272 A CH1648272 A CH 1648272A CH 1648272 A CH1648272 A CH 1648272A CH 534675 A CH534675 A CH 534675A
- Authority
- CH
- Switzerland
- Prior art keywords
- fluoro
- methylenprednisolone
- enanthate
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01R—ELECTRICALLY-CONDUCTIVE CONNECTIONS; STRUCTURAL ASSOCIATIONS OF A PLURALITY OF MUTUALLY-INSULATED ELECTRICAL CONNECTING ELEMENTS; COUPLING DEVICES; CURRENT COLLECTORS
- H01R4/00—Electrically-conductive connections between two or more conductive members in direct contact, i.e. touching one another; Means for effecting or maintaining such contact; Electrically-conductive connections having two or more spaced connecting locations for conductors and using contact members penetrating insulation
- H01R4/02—Soldered or welded connections
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01R—ELECTRICALLY-CONDUCTIVE CONNECTIONS; STRUCTURAL ASSOCIATIONS OF A PLURALITY OF MUTUALLY-INSULATED ELECTRICAL CONNECTING ELEMENTS; COUPLING DEVICES; CURRENT COLLECTORS
- H01R9/00—Structural associations of a plurality of mutually-insulated electrical connecting elements, e.g. terminal strips or terminal blocks; Terminals or binding posts mounted upon a base or in a case; Bases therefor
- H01R9/22—Bases, e.g. strip, block, panel
- H01R9/28—Terminal boards
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE1906586A DE1906586C3 (de) | 1969-02-11 | 1969-02-11 | 9 alpha-Fluor-16-fluormethylenprednisolon-21-önanthat, Verfahren zu seiner Herstellung und diese enthaltende pharmazeutische Zubereitung |
| CH96870A CH534673A (de) | 1969-02-11 | 1970-01-23 | Verfahren zur Herstellung von 9a-Fluor-16-fluor-methylenprednisolon-21-önanthat |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH534675A true CH534675A (de) | 1973-03-15 |
Family
ID=25686249
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1648172A CH534674A (de) | 1969-02-11 | 1970-01-23 | Verfahren zur Herstellung von 9a-Fluor-16-fluor-methylenprednisolon-21-önanthat |
| CH1648272A CH534675A (de) | 1969-02-11 | 1970-01-23 | Verfahren zur Herstellung von 9a-Fluor-16-fluor-methylenprednisolon-21-önanthat |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1648172A CH534674A (de) | 1969-02-11 | 1970-01-23 | Verfahren zur Herstellung von 9a-Fluor-16-fluor-methylenprednisolon-21-önanthat |
Country Status (1)
| Country | Link |
|---|---|
| CH (2) | CH534674A (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1970779B1 (de) | 2007-03-16 | 2009-09-09 | Richemont International S.A. | Uhr und Einsetzverfahren |
| EP3985450B1 (de) * | 2020-10-16 | 2024-08-28 | The Swatch Group Research and Development Ltd | Vorrichtung zum blockieren eines uhrwerks |
-
1970
- 1970-01-23 CH CH1648172A patent/CH534674A/de not_active IP Right Cessation
- 1970-01-23 CH CH1648272A patent/CH534675A/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CH534674A (de) | 1973-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT298508B (de) | Verfahren zur Herstellung von Mercaptoalkylalkoxysilanen | |
| AT302277B (de) | Verfahren zur Herstellung von Chinondiiminen | |
| CH526566A (de) | Verfahren zur Herstellung von 5-Pyridyl-2-imidazolonen | |
| CH508604A (de) | Verfahren zur Herstellung von Ureidophenylguanidinen | |
| CH533103A (de) | Verfahren zur Herstellung von 4-Acyloxy-azetidin-2-onen | |
| AT304774B (de) | Verfahren zur Herstellung von 16β-Methyl-9α-fluor-steroiden | |
| CH525881A (de) | Verfahren zur Herstellung von 4-Alkylprolinen | |
| CH505041A (de) | Verfahren zur Herstellung von Cycloalkenonen | |
| CH531480A (de) | Verfahren zur Herstellung von Aminoadamantanen | |
| AT319485B (de) | Verfahren zur Herstellung von 19-Norsteroiden | |
| AT296961B (de) | Verfahren zur Herstellung von Alkyldihydroxybenzolen | |
| CH511225A (de) | Verfahren zur Herstellung von Amidophenylthioharnstoffen | |
| CH529108A (de) | Verfahren zur Herstellung von y-Cyanbutyraldiminen | |
| AT308086B (de) | Verfahren zur Herstellung von 1-Alkoxyanthrachinonen | |
| CH530408A (de) | Verfahren zur Herstellung von Chinolylpiperazinen | |
| AT299905B (de) | Verfahren zur Herstellung von β-Acetoxypivalinaldehyd | |
| AT296297B (de) | Verfahren zur Herstellung von N-Tritylimidazolen und -triazolen | |
| CH530358A (de) | Verfahren zur Herstellung von 2-Methyl-4-halogen-but-2-en-1-alen | |
| CH532070A (de) | Verfahren zur Herstellung von 3-Methyl-isoxazol | |
| CH534675A (de) | Verfahren zur Herstellung von 9a-Fluor-16-fluor-methylenprednisolon-21-önanthat | |
| CH534135A (de) | Verfahren zur Herstellung von O-Carbamoylamidoximen | |
| CH534673A (de) | Verfahren zur Herstellung von 9a-Fluor-16-fluor-methylenprednisolon-21-önanthat | |
| AT299907B (de) | Verfahren zur Herstellung von Trimethyl-2-cyclohexen-1-onen | |
| AT296298B (de) | Verfahren zur Herstellung von N-Tritylimidazolen und -triazolen | |
| AT294833B (de) | Verfahren zur Herstellung von N-Tritylimidazolen und -triazolen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |